Every 10-Q that ACM Research, Inc. (ACMR) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow ACMR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ACMR filings page.
ACM Research, Inc. reported strong growth for the three and six months ended June 30, 2026. Revenue for the quarter was $292,919 (in thousands) versus $215,372 (in thousands) a year earlier, driven by higher sales of ECP, furnace and advanced packaging tools, while single‑wafer cleaning revenue declined. Gross margin was 46.0%, down from 48.5%, and income from operations rose to $49,743 (in thousands).
Net income attributable to ACM Research, Inc. increased to $88,984 (in thousands) for the quarter, with diluted EPS of $1.23, supported by a $69,592 (in thousands) unrealized gain on short‑term investments and $21,097 (in thousands) of income from equity method investments. Cash and cash equivalents reached $969,229 (in thousands), alongside short‑term investments of $105,091 (in thousands), after a $148.4 million registered direct offering and a $110.2 million sale of ACM Shanghai shares. The company generated negative operating cash flow of $35,896 (in thousands) for the first half, reflecting working capital investment, and continues to derive substantially all revenue from customers in mainland China with notable customer concentration and exposure to U.S. and mainland China regulatory regimes.
ACM Research, Inc. reports strong Q1 2026 growth, with revenue rising to $231.3 million from $172.3 million a year earlier, driven mainly by electrochemical plating, furnace and other technologies, and advanced packaging tools.
Gross margin was 46.4%, slightly below 47.9% last year, as product mix shifted. Net income attributable to ACM Research fell to $17.3 million from $20.4 million, and diluted EPS declined to $0.24 from $0.30, largely reflecting higher operating expenses and a larger foreign-exchange loss.
Cash, cash equivalents and restricted cash increased to $894.1 million, with an additional $358.2 million in short-term time deposits. Operating cash flow was a use of $29.5 million, while financing activities provided $163.4 million, including new borrowings and proceeds from selling approximately 4.8 million ACM Shanghai shares for about $110.2 million in gross proceeds, reducing ACM Research’s ownership in ACM Shanghai to 73.6%.
ACM Research (ACMR) filed its Q3 2025 10‑Q, reporting stronger results. Revenue was $269,160 for the quarter versus $203,976 a year ago, with diluted EPS of $0.52. For the nine months, revenue reached $656,879 and diluted EPS was $1.26. Net income attributable to ACM Research, Inc. was $35,889 in Q3.
Gross profit was $113,149 on cost of revenue of $156,011. Operating expenses rose to $84,226, led by higher R&D and SG&A. Cash and cash equivalents were $1,058,909 as of September 30, 2025. Operating cash flow for the nine months was $(44,244), while financing activities provided $738,115, including $622,964 of net proceeds from an issuance of shares by ACM Shanghai.
In September 2025, ACM Shanghai issued 38.6 million ordinary shares in a private offering, lowering ACM Research’s interest in ACM Shanghai from 81.1% to 74.6% at September 30, 2025. Shares outstanding were 59,854,640 Class A and 5,021,811 Class B as of November 3, 2025.